Introduction: This chapter describes the characteristics of adult patients starting renal replacement therapy (RRT) in the UK in 2008 and the acceptance rates for RRT in Primary Care Trusts and Local Authorities (PCT/LAs) in the UK. Methods: The basic demographics and clinical characteristics are reported on patients starting RRT from all UK renal centres. Late referral, defined as time between first being seen by a nephrologist and start of RRT being <90 days was also studied. Age and gender standardised ratios for acceptance rate in PCT/LAs were calculated. Results: In 2008, the acceptance rate in the UK was 108 per million population (pmp). Acceptance rates in Scotland (103 pmp), Northern Ireland (97 pmp) and Wales (117 pmp) have all fallen although Wales still remains the country with the highest acceptance rate. There were wide variations between PCT/LAs with respect to the standardised ratios, which were lower in more PCT/LAs in the North West and South East of England and higher in London, the West Midlands, Scotland, Northern Ireland, and Wales. The median age of all incident patients was 64.1 years and for non-Whites 56.1 years. Diabetic renal disease remains the single most common cause of renal failure (24%). By 90 days, 67.7% of patients were on haemodialysis, 19.8% on peritoneal dialysis, 5.9% had had a transplant and 6.6% had died or had stopped treatment. By 90 days, 77.4% of all dialysis patients were on HD. The geometric mean eGFR at the start of RRT was 8.6 ml/min/ 1.73 m 2 which was similar to the eGFR of those starting in 2007. The incidence of late presentation (<90 days) has fallen from 28% in 2003 to 22% in 2008. There was no relationship between social deprivation and referral pattern. Conclusions: Acceptance rates have fallen in Northern Ireland, Scotland and Wales whilst they have plateaued in England over the last three years. Wales continued to have the highest acceptance rate of the countries making up the UK.
Introduction
The term established renal failure (ERF) used within this chapter is synonymous with the terms end stage renal failure (ESRF) and end stage renal disease (ESRD), which are in more widespread international usage. Within the UK, patient groups have disliked the term 'end stage' which formerly reflected the inevitable outcome of this disease.
UK Renal Registry coverage
This chapter includes analyses of adult patients starting renal replacement therapy (RRT) in the UK in 2008. It describes regional and national variations in acceptance rates on to RRT in the UK, the demographics and clinical characteristics of all patients starting RRT in the UK and late referral to a renal centre for initiation of RRT. The methodology and the results for these analyses are discussed for the 3 sections separately.
For the first time, in 2008, the UK Renal Registry (UKRR) received individual patient level data returns from all adult renal centres in the UK (5 renal centres in Wales, 6 in Northern Ireland, 9 in Scotland and 52 in England). Data from centres in Scotland were obtained from the Scottish Renal Registry. Data on children and young adults can be found in chapter 14 Demography of the UK Paediatric RRT Population.
Geographical variation in acceptance rates
Over the years there have been wide variations in trends in acceptance between renal centres. Equity of access to RRT is an important aim and the need for RRT depends on many variables including social and demographic factors such as age, gender, social deprivation and ethnicity. Hence comparison of crude acceptance rates by geographical area can be misleading. This section, as in previous reports, uses age and gender standardisation and ethnic minority profiles to compare RRT incident rates. The impact of social deprivation was recorded in the 2003 report [1] .
Methods
Crude acceptance rates were calculated per million population (pmp) and standardised acceptance ratios were calculated as detailed in appendix D: methodology used for analyses of PCT incidence and prevalence rates and of standardised ratios (www.renalreg.org). Briefly, data from all covered areas was used to calculate overall age and gender specific acceptance rates. The age and gender breakdown of the population in each Primary Care Trust (PCT) area in England, Local Authority (LA) area in Wales, Scotland (called Council Area) and in Northern Ireland (called District Council Area) was obtained from the 2001 Census data from the Office for National Statistics (ONS) [2] . These will be referred to by the umbrella term 'PCT/LA' in this report. This population breakdown was extrapolated by the ONS from the 2001 census data to mid-2006 estimates. This is the second year that the mid-2006 estimates have been used. The population breakdown and the overall acceptance rates were used to calculate the expected age and gender specific acceptance numbers for each PCT/LA. The age and gender standardised acceptance ratio was the observed acceptance numbers divided by the expected acceptance numbers. A ratio below 1 indicated that the observed rate was less than expected given the area's population structure. This was statistically significant at the 5% level if the upper confidence limit was less than 1. Analyses were undertaken for each of the last 6 years and, as the incident numbers for one year can be small for smaller areas, a combined years analysis was also done. The proportion of non-Whites in each PCT/LA area was obtained from the ONS.
Results
In 2008 the number of adult patients starting RRT in the UK was 6,639 equating to an acceptance rate of 108 pmp (table 3.1), very similar to the rate of 109 pmp in 2007. Acceptance rates in Scotland (103 pmp), Northern Ireland (97 pmp) and Wales (117 pmp) have all fallen although Wales still remained the country with the highest acceptance rate (figure 3.1). In England, acceptance rates remained stable for the last 3 years. There continues to be very marked gender differences in take-on rates, 135 pmp (95% CI 131-139) in males and 82 pmp (95% CI 79-85) in females. Table 3 .2 shows acceptance rates and standardised ratios for PCTs and LAs. The 95% confidence intervals are given for the standardised ratios from the combined years analysis and ratios that are significantly different from 1 are highlighted, provided that the area has been covered for at least three years. Small differences in the 2003-2007 results may be seen in comparison with previous publications because of retrospective data updating in collaboration with local renal centres. In 2008 two small areas had no incident patients and hence crude acceptance rates of 0 pmp (table 3. 2). These were Shetland Islands (population 22,000) and Limavady (population 33,900). With just two/three incident patients respectively these areas would have had rates close to the national average. The highest rate was 262 pmp on the Isle of Anglesey (population 68,800). There were similar wide variations in the standardised acceptance ratios from 0 (the two areas as above) to 3.04 in the Heart of Birmingham PCT (population 271,400). The latter PCT has a 60% non-White population. Changes over the 6 years between 2003 and 2008 showed wide variations in annual standardised acceptance ratios, particularly as would be expected, in areas with small populations. Over this 6-year period, of those PCT/LA areas with data for a minimum of 3 years, 45 had significantly low ratios, 52 had high ratios and 118 normal ratios. There were significant differences between regions (p < 0.0001), with acceptance rates being lower in more PCT/LAs in North West and South East England and higher in London, the West Midlands, Northern Ireland, Scotland and Wales (table  3. 3). Importantly, the North East and North West of England have seen a rise in the number of PCT/LAs with significantly lower acceptance rates.
Confidence intervals are not presented for the crude rates but figure 3.2 has been included to enable assessment of whether an observed acceptance rate differs significantly from the national average. For any population size (x-axis), the upper and lower 95% confidence intervals around the national average acceptance rate (dotted lines) can be read from the y-axis. An observed acceptance rate outside these limits is significantly different from the national average. In order to be judged as significantly different from national norms the observed acceptance rate for a population of 80,000 would have to be outside the limits of 36 to 180 pmp per year, whilst for a population of 1 million, the limits are from 88 to 128 pmp per year. The plot begins at population 80,000 because below this the number of expected cases is small and the statistical assumptions used to produce the plot are not valid.
In those PCT/LA areas with significantly high acceptance ratios the median percentage of the population who were non-White was 20.6%, which was significantly higher (Wilcoxon rank sum test p < 0.001) than in those areas with low (2.3%) or normal (1.3%) ratios (figure 3.3). Likewise, those PCT/LAs with >10% of the population non-White (42 of 215 PCT/LAs) were significantly more likely to have high standardised acceptance ratios (p < 0.0001). Byrne/Ford/Gilg/Ansell/Feehally Byrne/Ford/Gilg/Ansell/Feehally 
Methods
Age, gender, primary renal disease, ethnic origin and first modality at start of RRT were examined in those patients starting RRT. Some centres electronically upload ethnicity coding to their renal information technology (IT) system from the hospital Patient Administration Systems (PAS). Ethnicity coding in these PAS systems is based on self-reported ethnicity and uses a different coding system [3] . For the remaining centres, ethnicity coding is performed by clinical staff and recorded directly into the renal IT system (using a variety of coding systems). For all these analyses, data on ethnic origin were grouped into Whites, South Asians, Blacks, Chinese and Others. The details of regrouping of the PAS codes into the above ethnic categories are provided in appendix G: Ethnicity and ERA-EDTA coding. Chi-squared, Fisher's exact, ANOVA and Kruskal Wallis tests were used as appropriate to test for significant differences between groups.
For the first time this year, rather than allocating all preemptive transplants to the transplanting centre, if an individual had a modality code 36 (transfer out pre-emptive transplant) from another centre up to 7 days before the transplant then Byrne/Ford/Gilg/Ansell/Feehally they were allocated to the 'transfer out'/'work up' centre rather than the transplanting centre. This affected 56 patients in 2008 and 101 of all take-on patients included in this year's analyses. Not all centres sent this level of data. Some patients remain incorrectly allocated to the transplanting centre. Estimated glomerular filtration rate (eGFR) at the start of RRT was studied amongst patients with eGFR data within 14 days before the start of RRT. The eGFR was calculated using the abbreviated 4 variable MDRD study equation [4] . For the purpose of the eGFR calculation, patients who had missing ethnicity but a valid serum creatinine measurement were classed as Whites. The eGFR values were log transformed in order to normalise the data. Patients with an eGFR >20 ml/min/1.73 m 2 were excluded from the eGFR analyses due to concerns about possible data extraction errors.
Derry was excluded from the centre-specific analyses as they started less than 10 patients on RRT in 2008.
Results

Age
Acceptance rates within the UK have levelled off in the last three years but were still rising in those aged 65 and over until 2006. It now looks like even in these patients acceptance rates have plateaued and are even falling slightly ( figure 3.4) .
In 2008, the median age of patients starting renal replacement therapy was 64.1 years (table 3.5). Patients starting in England were the youngest of the four countries of the United Kingdom and this reflects the higher percentage of ethnic minorities who make up the population in England. In Northern Ireland the There were large differences between centres with respect to the median age of their incident patients (figure 3.5). In 8 centres, the median age was <60 years and in 9 it was over 70 years. Possible explanations include chance fluctuations due to low take-on rates, the difference in the age structure of the underlying general population, the transplant status of the centre, variations in ethnic mix, differences in local approaches to conservative management, and other potential differences in the prevalence, nature and management of renal disease. The median age of patients in transplant centres remained slightly but significantly lower than that in non-transplant centres (62.5 vs. 65.4 years: p < 0.0001). Five of the 8 centres whose incident cohort had a median age <60 years were transplanting centres. Four of the 9 centres whose incident cohort had a median age >70 years accepted less than 40 patients during 2008.
Gender
As in previous UKRR reports there was an excess of males starting RRT in all age groups but this was more prominent with older age (figure 3.6). Peak acceptance rate was in the 75-79 year age band in both males and females. The proportion of males remained fairly stable with age but was most prominent in those aged >85 years ( figure 3.7) .
In the UK as a whole, 61.4% of the 2008 incident cohort were male (figure 3.8). The proportion of incident male patients varied from 42-79% between centres. All except five centres had an excess of incident males, whilst two were equally split male and female. It should be noted that five of these seven centres had accepted less than 50 patients during 2008. Likewise the three centres with >75% males accepted less than 40 patients for RRT in 2008. Wales, as last year, had a higher proportion of males starting RRT (66.8%, male to female ratio of 2).
Ethnicity
This year 49 centres who accepted more than 10 patients onto RRT, returned ethnicity data that were 50% or more complete (table 3.7). Only 23 of these centres provided data that were 90% or more complete. From Welsh centres there has been an increase in data returns. Ethnicity is not a mandatory data item for the Scottish Renal Registry. The lack of ethnicity completeness means results should be interpreted with some caution. All of the English centres who were last year recorded as having 100% white patients, had some ethnic mix this year. There was great variation between centres with respect to the ethnic mix of incident patients ranging from 0% ethnic minorities in Sunderland, Carlisle, Ipswich, Wrexham and all Northern Ireland centres to over 50% in Bradford, London Barts and London Royal Free; all the latter centres cover areas with high standardised acceptance ratios.
Primary renal diagnosis
The distribution of incident patients by age, gender and primary renal disease (PRD) is shown in table 3.8 and the distribution of primary renal disease by centre is shown in table 3.9. Data for PRD were missing in 10.8% of patients and there remains a marked centre difference in completeness of data returns. Thirty-five centres provided data on all incident patients, whilst 11 centres had more than 25% data incompleteness for PRD, one of which returned no data. In the centres with >25% missing data, the percentages in the other diagnostic categories have not been calculated.
The Registry is concerned about some of the centres with apparently 100% data completeness for PRD but who also have very high rates of 'uncertain' diagnoses (EDTA codes 00 and 10). It is accepted that there will inevitably be a number of patients with uncertain aetiology, and that the proportion of these patients will vary between clinicians and centres as the definitions of renovascular disease, hypertensive nephropathy and chronic glomerulonephritis without tissue diagnosis remain relatively subjective. However, some centres with very high rates of uncertain diagnosis appear to have no patients with the more objective diagnoses such as polycystic kidney disease, reflux nephropathy, diabetic nephropathy or biopsy-proven glomerulonephritis, which is clearly improbable. Preliminary enquiries have shown that software in these centres, by default, assigns patients whose data is missing the code for 'uncertain' (EDTA code 00). These centres have now taken steps to rectify this, so that only patients in whom the clinician is genuinely uncertain as to the PRD will be assigned the 'uncertain' PRD code. Five centres with >45% 'uncertain' diagnoses have been excluded from further analyses, because it is likely that the estimates of incidence of specific PRDs in these centres are falsely low. These centres have also been excluded from other analyses where PRD is included in the case-mix adjustment. This is more easily seen in figure 3.9. The centres on the right hand side of the graph have high rates of incomplete data returns and those with excessive or high uncertain diagnostic codes that have been excluded from table 3.9 are seen to the left. It is also more apparent that while many centres have a spectrum of diagnostic codes, their aggregate numbers are similar. This may reflect the subjectivity of softer diagnostic categories (renal vascular disease, hypertension, glomerulonephritis-no biopsy and CKDuncertain). Diabetic nephropathy was the most common specific renal diagnosis accounting for 24% of incident diagnoses (having excluded patients with missing data). This was the case irrespective of age, though the proportion was slightly higher in those aged <65 years. Biopsy proven glomerulonephritis (15.2% vs. 8.1%) and adult polycystic kidney disease (10.9% vs. 3.4%) were much more common in the younger incident cohort, whilst renal vascular disease was much more common in older incident patients (12.2% vs. 2.0%). It was perhaps not surprising that uncertainty about the underlying diagnosis was also more common in the older cohort (26.1% vs. 15.8%).
The proportion of each major diagnosis has changed little in the last few years.
For all primary renal diagnoses except polycystic kidney disease, the male to female ratio was greater than 1.5. This gender difference may relate to factors such as hypertension, atheroma and renal vascular disease, which are more common in males and more common with increasing age. These factors may influence the rate of progression of renal failure. As would be expected from the mode of inheritance, adult polycystic kidney disease (PKD) is a major exception, the ratio approximating one in this condition.
Taking into account the excluded centres outlined above, there has been a further slight reduction in the UK as a whole with respect to uncertain aetiology (20.7%), although there is great variation between centres. Some of this variation is likely to reflect the lack of a clear definition of certain diagnostic categories e.g. hypertensive renal disease and renal vascular disease; some may result from differences between centres in attitudes to the degree of certainty required to record other diagnoses. In keeping with this, there are significant negative correlations between the frequency of uncertain diagnosis and all other diagnostic categories.
The proportion of incident patients whose primary renal disease was recorded as diabetes varied between centres from 8% to 36%. Having excluded those centres with very high 'uncertain' PRD rates, no centres reported zero patients with diabetic nephropathy and only one centre reported a rate of <10%. These low rates may relate to chance fluctuations due to low take-on numbers and the ethnic mix of the incident population. Of the 12 centres reporting that 30% or more of their incident cohort had diabetes as the primary renal disease, 4 reported a high proportion of non-Whites in the incident population (27-72%) and a further 5 took on 56 patients or fewer in 2008. These factors undoubtedly contribute to the variation between centres with respect to the proportion of other primary renal disease in the incident cohort, as well as the variable diagnostic criteria in disease categories such as hypertension and renal vascular disease. Table 3 .10, showing the PRD incidence rates per million population in the 2008 cohort in the four home countries, reveals some national variations. There were no missing data for Northern Ireland and only 1.5% for Wales, whilst England and Scotland had 11.5% and 13.5% respectively. The incidence rate of uncertain diagnoses was higher in Northern Ireland (25.4 pmp) and Wales (24.3 pmp) than in Scotland (16.8 pmp) and England (20.3 pmp). The incidence of diabetes was much higher again in Wales (32.4 pmp) than in England (23.4 pmp), Northern Ireland (20.3 pmp) and Scotland (20.5 pmp). Likewise the incidence rate of renal vascular disease causing ERF was higher in Wales than other parts of the UK.
First established treatment modality
In the UK in 2008, haemodialysis (HD) was the first modality of RRT (defined as the first treatment recorded irrespective of any later change) in 75.8% of patients, peritoneal dialysis (PD) in 18.9% and pre-emptive transplant in 5.3%. The frequency of HD as the first treatment modality has remained relatively stable over the last few years, though it has increased considerably since the late 1990s (58% of incident patients in 1998). The frequency of PD usage however has fallen whilst pre-emptive transplantation has risen. This may be as a consequence of drives nationally to encourage live donation and pre-emptive transplantation and it is the 'fitter' patients approaching ERF who traditionally have started on PD.
Many patients, especially those referred late, undergo a brief period of HD, before switches to other modalities are, or can be, considered. Hence, the established modality at 90 days is more representative of the elective first modality. By 90 days in the 2008 UK cohort, 6.2% of incident patients had died and a further 0.4% had stopped treatment, leaving 93.4% of the original cohort remaining on RRT (table 3.11). Expressed as a percentage of the whole 2008 UK incident cohort, 67.7% were on HD, 19.8% on PD and 5.9% had received a transplant. Expressed as a percentage of those still receiving RRT at 90 days, 72.5% were on HD, 21.2% on PD and 6.3% had received a transplant (figure 3.10). Of those still on RRT at 90 days, only 0.1% were receiving home haemodialysis, with the vast majority of HD patients on centrebased treatment either in main hospital centres (48.6% of total) or satellite units (20.5%). Although Northern Ireland continued to have fewer patients on PD at 90 days (15.1% of the total incident cohort) compared with other parts of the UK, this was an increase from 9.1% of the 2007 incident cohort. The percentages in the 3 other countries have all fallen, most dramatically in Wales (24.6% to 20.9%) and Scotland (21.3% to 18.1%). This comes at a time when the Department of Health is trying to increase the proportion of patients on home therapies, of which PD is the most common. Although the median age of patients starting RRT has not increased in latter years it may be that is a group of patients with increasing comorbidity who are unsuitable for PD. The percentage of incident patients who had died by day 90 varied considerably between centres (0% to 19%, table 3.11). The definition of whether patients have acute or chronic renal failure may be a factor in this apparent variation. Many other factors probably contribute to these differences including centre size, age and attitudes to conservative therapy and 'trials of dialysis' for borderline dialysis candidates. Three of the five centres with a death rate above 14% accepted 50 or fewer patients and all 5 centres had a median age higher than the UK incident median (2 centres had a median age over 70 years). This may also account for some of the variation in the proportions stopping treatment during the first 90 days.
The range in the proportion of incident patients who had a functioning transplant at 90 days was 0 to 22%. Of the 26 centres in which more than 5% of their incident cohort had received a transplant by 90 days, 23 were transplant centres. The mean percentage of the incident cohort with a functioning transplant by 90 days was significantly greater in transplanting compared to nontransplanting centres (8.9 vs. 3.2%: p < 0.0001). One possible reason could be that patients transplanted preemptively or early were attributed to the incident cohort of the transplanting centre rather than that of the referring centre (see below).
There were also major differences between individual centres in the percentage of new dialysis patients established on HD at 90 days (range 39.8-95.5%, table 3.11). Some of the centres with low HD numbers had high transplant numbers at day 90 (London Guys, London St Georges and Plymouth), whilst others had high PD numbers (Doncaster, London Barts, Reading, Manchester Hope and Dumfries). As discussed above, it is likely that some of the variation seen in transplant rates is artificial. For example, Dorset has 6% of patients transplanted by day 90, compared with 1.9% at London Kings. The likely explanation is that many of the patients who started RRT at Kings remain allocated to the transplanting centre (London Guys). Four centres had 40% or more of their incident dialysis patients on PD at day 90. Two of these four took on 40 or less patients during 2008.
Older patients were more likely to be on HD rather than PD at 90 days (median age on HD 66.1 years vs. PD 58.3 years). In the UK as a whole, 71.1% of incident patients aged less than 65 years were on HD at this stage compared with 84.0% of patients aged over 65 (p < 0.001) (table 3.12). The percentage of patients on PD at 90 days was almost twice as high in patients aged <65 years as in older patients (28.9 % vs. 16.0%). In only 6 centres (London West, London Barts, Chelmsford, York, Ipswich and Coventry) was this trend reversed and they were all different to the 7 centres from last year; these centres had a higher proportion of older patients on PD.
Between centres there was a large variation between the male:female ratio of patients on HD and PD (figure 3.11). Within the UK there was no significant difference in the male:female ratio of incident patients on HD and PD.
Renal function at the time of starting RRT The mean eGFR at initiation of RRT in 2008 was 8.6 ml/min/1.73 m 2 . This was highest in patients who were aged 85 and over, at 9.1 ml/min/1.73 m 2 (figure 3.12). There was a trend of increasing eGFR at initiation of RRT with increasing age.
When analysing serial data from centres reporting annually to the UKRR since 1997, figure 3.13 shows a continued tendency over the last 4 years to initiate PD at a higher mean eGFR than HD patients. In patients starting HD, there may be some plateauing of this level around an eGFR of 8.5 ml/min/1.73 m 2 . Some caution should be applied to the analysis of eGFR at the start of RRT. A review of pre-RRT biochemistry in nine renal centres revealed that up to 18% of patients may have an incorrect date of start of RRT allocated (by up to 5 weeks). In these patients, the 
Introduction
Late presentation to a nephrologist has many definitions and a range of possible causes. Chronic kidney disease may be asymptomatic until very advanced stages and patients may present with a variety of rapidly progressive glomerulopathies that present late and should be termed 'late presenters'. In contrast there are patients with chronic kidney disease, who may be regularly monitored in primary or secondary care, and referral to nephrological services has been delayed (late referral). The analyses presented encompass all these possibilities in any patient referred to renal services within 90 days of requiring RRT.
Methods
Data were included from all incident patients in the years [2003] [2004] [2005] [2006] [2007] [2008] . The date first seen in a renal centre and the date of starting RRT were used to calculate the referral time. This is the number of days between first being seen and starting RRT. Two percent of data were excluded because of actual or potential inconsistencies. Only data from those centres with 75% or more completeness were used. Data were excluded for centres in the years where 10% or more of the patients were reported to have started RRT on the same date as the first presentation. After these exclusions, data on 9,913 patients were available for analysis. Referral times of 90 days or more were defined as early presentation. Referral times of less than 90 days were defined as late presentation.
Results Table 3 .13 shows the percentage completeness of data from 2003 to 2008 excluding centres with 10% or more of start dates for RRT being on the same day as first presentation. Overall there has been no change in the proportion of patients analysed with a reported date of referral.
Late presentation by centre and year Late presentation ranged by centre from 8-41% in patients commencing RRT in 2008 (table 3.14). The overall rate of late presentation was 22.2%, comparable with last year.
There had been a steady decline nationally in the proportion of patients referred late to renal services in the previous 2 years. This may have been as a consequence of the National CKD guidelines published by the Medical and GP Royal Colleges [6] and the Quality and Outcomes Framework (QOF) initiative (www.dh.gov.uk) raising awareness of CKD amongst non-nephrologists. The incidence rate may have now plateaued, though some centres achieve <10% late presentation rates. The reasons for this are probably multifactorial and may include education policies, local referral guidelines and use of remote IT monitoring. n/a n/a n/a n/a n/a 0. Time referred before dialysis initiation in the 2008 incident cohort In 2008, 62.5% of incident patients had been referred over a year before they needed to start dialysis. There were 9.2% of patients referred within 6-12 months, 6.2% within 3-6 months and 22.2% within 3 months. Table 3 .15 shows data relating to time referred before dialysis initiation from those 8 centres supplying data for each of the last 6 years with >75% completeness (Basildon, Dorset, Nottingham, Oxford, Portsmouth, Sheffield, Stevenage and Wolverhampton). The proportion of patients presenting late in these centres since 2003 has steadily fallen, particularly since 2005 (figure 3.14), and similarly there has been an increase in those presenting 12 months or more before starting RRT.
Age and late presentation
In the 2003-2008 cohort, patients who presented late were significantly older than patients who presented earlier (>90 days before dialysis initiation) (median age 66.9 vs. 64.8 years: p < 0.0001). Furthermore, the median duration of pre-dialysis care diminished progressively with increasing age beyond the 45-54 age group (figure 3.15).
Gender and late presentation
There was no significant difference in the proportion of males and females by time of presentation (male:female ratio 1.66 in early presenters, 1.72 in late presenters, p ¼ 0.47).
Ethnicity, social deprivation and late presentation
This analysis of the 2003-2008 cohort was limited to patients from centres with >70% ethnicity and >75% referral time data. Patients from the Chinese and Other ethnic minority groups were excluded due to the small numbers with referral data. The percentage of nonWhites (South Asian and Black) presenting late (<90 days) was significantly lower than in Whites (21.2% vs. 25%: p ¼ 0.013). The high incidence of diabetes in non-Whites (as discussed below, patients with diabetes tended to be referred earlier) and the older median age of incident Whites, may have a bearing. There was no relationship between social deprivation and referral pattern.
Primary renal disease and late presentation
In the 2003-2008 cohort, late presentation differed significantly between primary renal diagnoses (Chisquared test p < 0.0001) (table 3.16). Patients with a diagnosis of 'other identified category', 'not available', and the aetiology uncertain/glomerulonephritis unproven groups appeared to have higher rates of late referral. Those with diabetes and adult polycystic kidney disease had lower rates. Modality and late presentation In the 2003-2008 cohort, late presentation was associated with variations in initial choice of modality. The percentage of patients whose first modality was PD was significantly less in the late presentation group compared to those presenting earlier (11.5% vs. 27.4%: p < 0.0001). By 90 days after dialysis initiation this difference was reduced, although still highly significant (17.6% vs. 29.0%: p < 0.0001). This pattern has been evident for the last few years with little improvement in PD rates in the late presenters.
Comorbidity and late presentation
In the 2003-2008 cohort, significantly fewer patients who had presented late were assessed as having no comorbidity when compared with the group who presented earlier (40.1% vs. 43.6%: p ¼ 0.014). Peripheral vascular disease was significantly less common in the group presenting late. Malignancy was significantly more common in those presenting late, perhaps because of the potential for rapid decline in renal function in this setting (table 3.17).
Haemoglobin and late presentation In the 2003-2008 cohort, patients presenting late had a significantly lower haemoglobin concentration at dialysis initiation than patients presenting earlier (9.5 vs. 10.5 g/dl: p < 0.0001). This may reflect inadequate pre-dialysis care with limited anaemia management, but alternatively those presenting late may be more likely to have anaemia because of multisystem disease or intercurrent illness.
eGFR at start of RRT and late presentation In the data set 2003-2008, eGFR was lower in patients who presented late (7.6 vs. 8.3 ml/min/1.73 m 2 : p < 0.0001), both in males (7.8 vs. 8.5: p < 0.0001) and females (7.3 vs. 7.9: p ¼ 0.0001). The same relationship held in older patients (>65 years) (7.8 vs. 8.5: p < 0.0001) and in younger patients (18-44 years) (6.8 vs. 8.1: p < 0.0001), but not in those in the intermediate age range (45-64 years) (7.6 vs. 8.0: p ¼ 0.06). Similarly the relationship held in Whites (7.6 vs. 8.3: p < 0.0001) and Asians (7.0 vs. 7.9: p ¼ 0.05) but not in Blacks (8.1 vs. 7.7: p ¼ 0.6). It should be noted that patient numbers were small in ethnic minority groups.
eGFR at start of RRT was significantly lower in patients presenting late rather than early with renal disease of uncertain aetiology (6.9 vs. 8.0: p < 0.0001) and 'other diagnoses' (7.5 vs. 8.2: p ¼ 0.0009). No differences were seen in any of the other diagnostic categories. When stratifying by comorbidity, eGFR was significantly lower in patients who presented late compared to earlier presentation in all comorbidity groups except cerebrovascular and peripheral vascular disease and diabetes. For example, amongst patients with liver disease, the eGFR at the start of RRT was 8.7 in those who presented early compared to 6.7 in those who presented late (p ¼ 0.0004).
Survival of incident patients
This analysis is to be found in chapter 7 Survival and Causes of Death in UK Adult Patients on RRT in 2008.
Summary
For the first time this year, the UKRR had individual patient level coverage of all UK renal centres compared with last year's report when one centre could only provide centre level data. This has enabled acceptance rates to be more accurately assigned to centres. Acceptance rates have fallen in Northern Ireland, Scotland and Wales whilst they have plateaued in England over the last 3 years. Wales continues to have the highest acceptance rates but it may be that the other parts of the UK are tending towards more similar rates. There remain large centre variations in acceptance rates for RRT and they are significantly affected by age, gender, primary renal diagnosis and ethnicity. Significant numbers of patients continue to present late to renal centres and the improvement of recent years may have halted.
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